The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2015
Filed:
Dec. 15, 2014
Applicant:
Glaxo Group Limited, Brentford, Middlesex, GB;
Inventors:
Assignee:
Glaxo Group Limited, Brentford, Middlesex, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 239/36 (2006.01); C07D 239/52 (2006.01); C07D 239/56 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 413/06 (2006.01); C07D 417/06 (2006.01); C07D 239/22 (2006.01); C07D 239/47 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
C07D 403/14 (2013.01); C07D 239/22 (2013.01); C07D 239/36 (2013.01); C07D 239/47 (2013.01); C07D 239/52 (2013.01); C07D 239/56 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01);
Abstract
The present invention relates to novel compounds that inhibit Lp-PLAactivity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.